UK markets open in 8 minutes

Genfit SA (GNFT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
4.0800-0.0400 (-0.97%)
At close: 04:00PM EST
4.0000 -0.08 (-1.96%)
After hours: 04:49PM EST
Sign in to post a message.
  • B
    GNFT should be up to $10 on this new deal. It's giving them around $500 million in cash and milestones, and they get 20% of the revenue from the sales of the commercialization. That's a large amount of cash, probably will end up being around $1 billion in cash. Not sure why they only added $2 to the stock price today.
  • M
    ⭐ Top Bullish Charts | December 2021 💰💵📈
  • p
    If you're looking for a short and sweet guide to the day's biggest news, I recommend ( They breakdown the most important pre-market news and it only takes a few minutes to read.
  • h
    They had some interesting insights about GNFT on ( Definitely made me think twice about the company.
  • D
    Yesterday was interesting day. Touched new highs in long time. I expect gnft to keep getting accumulated through dec 31st. EOY close might be in 7-8 range. Double digits q1. It is clear, this is a happening stock for 2022 and beyond. I down collaboration and cash for PBC, NashNext diagnostic test sales by LabCorp and moving on with other pipeline indications. We might see 20s again in 2023. I wish GNFT had options, that would give us some cash monthly by selling covered calls. I’m very positive on future of GNFT , it’s a 12-18 months hold though.
  • s
    120 Euros = $135.6Mil in cash upfront.

    That's $3.30 per share. Stock is only up $2 on the news. Up $3.30, that would have a share price of at the very least, $6.60 per share.

    Add the 28Mil Euro ($31,600,000) investment for 3,985239 shares (or $7.94 per share) and this company should have a share price of at least $6.70.

    Very undervalued here considering the promising future with this deal.
  • B
    (PYPD) $5.70 -BIG Blockbuster with imminent Phase 3 readout/ Cathie Wood´s ARK Investment holding a large stake = 1000% opp

  • b
    SLGL $6.60...BIG FDA approval expected within weeks =500%+ UPSIDE
    Pipeline - Sol-Gel
  • g
    Is there anybody who Doesn't have a discord group for this stock? lol!
  • J
    Stock is likely not moving because their phase 3 trial is only due 2023 Sep and follow up thru 2028.... They need to drastically reduce cash burn to survive till then.
  • S
    Expect $280 Million Stock Offering News
    Monday AM.--12/20/2021
  • A
    What would happen Monday?
  • T
    Terminal Gravity
    Short attack! This stock has a low float and short interest is off the charts right now. Glad I'm long.
  • Y
    Yahoo Finance Insights
    GNFT is up 13.21% to 6.00
  • P
    I Wonder IF this is going to be top 3 highest gainer today🧐📈
  • Y
    Yahoo Finance Insights
    GNFT is up 12.97% to 5.75
  • Y
    Yahoo Finance Insights
    GNFT is up 7.22% to 3.27
  • r
    $GALT conversation
    Galectin commences its adaptive phase 3 trial. Genfit flunks its phase 3 trial.
    Galectin commences its adaptive phase 3 trial. Genfit flunks its phase 3 trial.
  • A
    Very quiet board...

    Sometimes, still waters run deep :-)

    Anyone looking at Genfit and elafibranor for the first time (bearing in mind that the Big catalyst is the phase 3 readout in late 2019) might like to know that elafibranor was recently awarded Breakthrough Therapy status in PBC.

    Also, Barclays initiates coverage on 224 at Overweight with a PT of 55 USD (120% upside)